---
figid: PMC3227953__onc0031005710001
figtitle: PI3K/Akt/mTOR pathway signaling in tumor and vascular endothelial cells
organisms:
- Homo sapiens
pmcid: PMC3227953
filename: onc0031005710001.jpg
figlink: /pmc/articles/PMC3227953/figure/F1/
number: F1
caption: 'PI3K/Akt/mTOR pathway signaling in tumor and vascular endothelial cells.
  The PI3K/Akt/mTOR pathway (A) and molecular targets for treatment in renal cell
  carcinoma (B).Abbreviations: 4E-BP1, eukaryotic initiation factor 4E binding protein
  1; HIF, hypoxia-inducible factor; mTOR, mammalian target of rapamycin; PDGF, platelet-derived
  growth factor; PDGFR, PDGF receptor; PI3K, phosphatidylinositol 3-kinase; S6K1,
  S6 kinase 1; TSC, tuberous sclerosis complex; VEGF, vascular endothelial growth
  factor; VEGFR, VEGF receptor; VHL, von Hippel-Lindau.'
papertitle: 'Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma:
  A Review.'
reftext: Sanjiv S. Agarwala, et al. Oncologist. 2010 Mar;15(3):236-245.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9385695
figid_alias: PMC3227953__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3227953__F1
ndex: bcbac9d5-deeb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3227953__onc0031005710001.html
  '@type': Dataset
  description: 'PI3K/Akt/mTOR pathway signaling in tumor and vascular endothelial
    cells. The PI3K/Akt/mTOR pathway (A) and molecular targets for treatment in renal
    cell carcinoma (B).Abbreviations: 4E-BP1, eukaryotic initiation factor 4E binding
    protein 1; HIF, hypoxia-inducible factor; mTOR, mammalian target of rapamycin;
    PDGF, platelet-derived growth factor; PDGFR, PDGF receptor; PI3K, phosphatidylinositol
    3-kinase; S6K1, S6 kinase 1; TSC, tuberous sclerosis complex; VEGF, vascular endothelial
    growth factor; VEGFR, VEGF receptor; VHL, von Hippel-Lindau.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - AKT1
  - AKT2
  - AKT3
  - OTOR
  - EIF4EBP1
  - RPS6KB1
  - KDR
  - FLT1
  - FLT4
  - PDGFRB
  - PDGFRA
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - VHL
  - XIC
  - Temsirolimus
  - Cancer
---
